Free tool
Diagnostics stocks
We cover 9 companies grouped under the Diagnostics theme. The median market value in the group is $4.72B. Across the group, the median move over the past trading day is +2.32%. Price change over the past year runs from −27.4% to +118.4% across the middle 80 percent of the group, with a median of −8.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
9 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −10.74% | Nov 4, 2026 |
| QIA.DE | Qiagen N.V. | $8.85B | Mid cap | −11.42% | Nov 4, 2026 |
| 6869.T | Sysmex Corporation | $7.42B | Mid cap | +5.65% | Nov 4, 2026 |
| CAI | Caris Life Sciences, Inc. | $7.38B | Mid cap | −27.21% | Nov 4, 2026 |
| BLLN | BillionToOne, Inc. | $4.72B | Mid cap | −8.14% | Nov 5, 2026 |
| WGS | GeneDx Holdings Corp. | $2.61B | Mid cap | −28.28% | Oct 27, 2026 |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +107.86% | Oct 8, 2026 |
| NEO | NeoGenomics, Inc. | $2.19B | Mid cap | +160.31% | Oct 27, 2026 |
| ALIF-B.ST | AddLife AB (publ) | $2.09B | Mid cap | −7.56% | Oct 21, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.